A case of a malignant peritoneal mesothelioma mimicking an autoinflammatory syndrome in a 12-year-old boy is reported. The patient initially presented with lymphadenopathy and weight loss but without abdominal pain. Three things confounded the initial diagnosis: a positive test result for a gene related to cryopyrin-associated periodic syndrome, a positive response to the autoinflammatory syndrome treatment, and a lymph node biopsy which showed “hyperplastic mesothelial cells in the lymph sinuses.” His symptoms relapsed several years later, and a peritoneal biopsy confirmed the final diagnosis. Complete morphological, immunohistochemical, and molecular diagnoses are described. A translocation in the TERT gene involving the truncation of the promoter was found in the mesothelioma. The translocation has never been described in mesotheliomas and is of an unknown significance.
ThomasAChenYYuTGillAPrasadV.Distinctive clinical characteristics of malignant mesothelioma in young patients. Oncotarget. 2015;
6(18):16766–16773.
2.
FraireAECooperSGreenbergSDBufflerPLangstonC.Mesothelioma of childhood. Cancer. 1988;
62(4):838–847.
3.
TestaJRCheungMPeiJ, et al.
Germline BAP1 mutations predispose to malignant mesothelioma.Nat Genet. 2011;
43(10):1022–1025.
4.
DesmeulesPJoubertPZhangL, et al.
A subset of malignant mesotheliomas in young adults are associated with recurrent EWSR1/FUS-ATF1 fusions.Am J Surg Pathol. 2017;
41(7):980–988.
5.
HusainANColbyTVOrdonezNG, et al.
Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2018;
142(1):89–108.
StromSP.Current practices and guidelines for clinical next-generation sequencing oncology testing. Cancer Biol Med. 2016;
13(1):3–11.
8.
ObertoCSchwarzKBZambidisE, et al.
Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease. Dig Dis Sci. 2004;
49(3):434–437.
9.
BerryPJFavaraBEOdomLF.Malignant peritoneal mesothelioma in a child.Pediatr Pathol. 1986;
5(3–4):397–409.
10.
PengLShenQLiuX, et al. Diffuse hyperplastic mesothelial cells in multiple lymph nodes: case report with review of the literature. Int J Clin Exp Pathol. 2013;
6(5):926–931.
11.
ArganiPRosaiJ.Hyperplastic mesothelial cells in lymph nodes: report of six cases of a benign process that can stimulate metastatic involvement by mesothelioma or carcinoma.Hum Pathol. 1998;
29(4):339–346.
12.
GrundyGWMillerRW.Malignant mesothelioma in childhood. Report of 13 cases. Cancer. 1972;
30(5):1216–1218.
13.
PriceBWareA.Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.Am J Epidemiol. 2004;
159(2):107–112.
14.
CioffrediLAJhaveriR.Evaluation and management of febrile children: a review.JAMA Pediatr. 2016;
170(8):794–800.
15.
MoranCAAlbores-SaavedraJSusterS.Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases. Histopathology. 2008;
52(7):824–830.
16.
SugalskiADavisMPrasannanLSaldivarVHungJYTomlinsonGE.Clinical, histologic, and genetic features of mesothelioma in a 7-year-old child.Pediatr Blood Cancer. 2013;
60(1):146–148.
17.
GongYSRongYTHanWCZhangYC.Peripheral lymphadenopathy as the initial manifestation of malignant mesothelioma in a child.Hum Pathol. 2013;
44(4):664–669.
18.
LanphearBPBuncherCR.Latent period for malignant mesothelioma of occupational origin.J Occup Med. 1992;
34(7):718–721.
19.
MuraliRWiesnerTScolyerRA.Tumours associated with BAP1 mutations.Pathology. 2013;
45(2):116–126.
20.
WiesnerTFriedIUlzP, et al.
Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.J Clin Oncol. 2012;
30(32):e337–e340.
21.
LoharamtaweethongKPuripatNAoonjaiNSutepvarnonABandidwattanawongC.Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum.Histopathology. 2016;
68(4):603–607.
22.
HungYPDongFWatkinsJC, et al.
Identification of ALK rearrangements in malignant peritoneal mesothelioma.JAMA Oncol. 2018;
4(2):235–238.
23.
MianIAbdullaevZMorrowB, et al.
Anaplastic lymphoma kinase gene rearrangement in children and young adults with mesothelioma.J Thorac Oncol. 2020;
15(3):457–461.
24.
RuschoffJHGradhandEKahramanA, et al.
STRN-ALK rearranged malignant peritoneal mesothelioma with dramatic response following ceritinib treatment. JCO Precis Oncol. 2019;
3:▪.
25.
MijalovskyAHalperinDPerezY, et al.
Malignant peritoneal mesothelioma in an infant with familial ATM mutations.J Pediatr Hematol Oncol. 2018;
40(8):e511–e515.
26.
HuangDSWangZHeXJ, et al.
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.Eur J Cancer. 2015;
51(8):969–976.
27.
TalletANaultJCRenierA, et al.
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma. Oncogene. 2014;
33(28):3748–3752.
28.
KawashimaMUedaYKuriharaSHiyamaE.TERT promotor region rearrangements analyzed in high-risk neuroblastomas by FISH method and whole genome sequencing.Int J Clin Oncol. 2020;
25(12):2166–2174.
